What we know about the Alzheimer's drug Health Canada approved
CBC
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about its effectiveness and availability in Canada.
Lecanemab is a lab-made antibody given by intravenous infusion. It targets the buildup of amyloid plaque in the brain, a hallmark of Alzheimer's disease.
Lecanemab is not a cure and cannot reverse the disease or restore lost memories.
The Alzheimer Society of Canada calls it the first disease-modifying Alzheimer's treatment approved for use in the country. Current medications mitigate symptoms rather than change the course of the disease.
How well the drug works and its potential impact on Canada's health-care systems are now considerations for people with the disease, their families, physicians and governments.
Lecanemab, also known by the brand name Leqembi, is approved to treat mild cognitive impairment and early stages of Alzheimer's disease.
Patients must have a documented presence of amyloid plaque in the brain, Canada's Drug Agency said.
Patients must also seek testing for gene variants associated with negative side-effects. The new treatment is only available for patients with a single or no copy of a gene variant called APOE4. Patients with two APOE4 copies are more likely to experience swelling or bleeding in the brain.
Access to the required genetic testing varies across provinces and territories.
When someone is diagnosed with dementia, a common fear is losing the ability to stay independent, said Dr. Samir Sinha, a geriatrician and clinician scientist at Sinai Health and the University Health Network in Toronto.
"Right now, it takes about 18 months before you might notice some sort of significant difference," Sinha said.
It's estimated 750,000 Canadians live with dementia and about 500,000 of them have a diagnosis, said Sinha. By the time a lot of people receive a formal diagnosis, they may no longer be good candidates for this medication, he said.
Sinha said he thinks more research is needed to answer whether lecanemab's benefits are worth the $26,000 US it costs in other countries. He questioned whether the results would be noticeable enough to allow patients to stay independent.
"It's a positive development that there's another medication that's been approved and it's available, but it's not necessarily a medication that would be the most practical one for me to prescribe or recommend for the majority of my patients."
Frank Gehry, the Canadian-born renegade architect behind some of the world's most recognizable buildings, has died at 96.
Hundreds of P.E.I. parents can't find child-care spaces, especially for infants. The provincial government says expanding those spots remains a top priority — and it recognizes the concern.
An Alberta judge says a referendum proposal on Alberta separating from Canada goes against Charter and and Treaty rights, in a decision given less than 24 hours after the provincial government introduced legislation that would have ended the court proceeding.
The architect of Alberta's politician recall legislation says it was never meant to be used as a political weapon, but as an "ultimate tool of accountability" if a politician engages in illegal or unethical behaviour.
The Government of Saskatchewan has introduced its long-promised involuntary treatment legislation on the final day of the fall sitting.
The Law Society of Ontario has suspended the licence of Deepak Paradkar, one of seven Canadians arrested in connection with alleged drug lord Ryan Wedding’s cocaine smuggling ring.
London Health Sciences Centre (LHSC) is getting rid of unlimited mental health benefits for staff, blaming ballooning costs and former administrators for implementing it without proper due diligence or oversight.
Netflix has agreed to buy Warner Bros. Discovery's TV and film studios and streaming division for $72 billion US, a deal that would hand control of one of Hollywood's most prized and oldest assets to the streaming pioneer that has upended the media industry.
CBC Calgary kicks off its annual Make the Season Kind campaign this morning at Fratello Coffee Roasters.
CBC Newfoundland and Labrador is kicking off its annual holiday campaign, helping to raise money to support local food banks.
If all goes according to plan, at 6 a.m. AT on Saturday people working at the IWK Health Centre will become the test case for a generational change to Nova Scotia’s health-care system.
One month after Prime Minister Mark Carney announced what he called "generational" military spending, New Brunswick’s defence ecosystem is on high alert.
Miranda Mirlycourtois, 34, looks directly at the camera and makes a confession.